Obinutuzumab
About
Therapy type: Targeted therapy
Therapy strategy: CD20 inhibition
Mappings
NCI Thesaurus: Obinutuzumab (coding:ncit:C70741)
RxNorm: obinutuzumab (coding:rxcui:974779, coding:omop:44507676)
SNOMED: Obinutuzumab (coding:sctid:710287009, coding:omop:46271994)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| HSE (2) | CD20 + | Follicular Lymphoma | Bendamustine, Obinutuzumab | |
| HSE (1) | CD20 + | Follicular Lymphoma | Cyclophosphamide, Doxorubicin, Obinutuzumab, Prednisolone, Vincristine | |
| HSE (1) | CD20 + | Follicular Lymphoma | Cyclophosphamide, Obinutuzumab, Prednisolone, Vincristine |